MEDCAC Q&A with Louis Jacques, ADVI Chief Medical Officer
On May 16, the Centers for Medicare and Medicaid Services (CMS) released a tracking sheet for a National Coverage Analysis (NCA) for Chimeric Antigen Receptor (CAR) T-cell therapies. CMS simultaneously announced an August 22 public meeting of its Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) advisory panel meeting on CAR-T therapies.
[el-text]
MEDCAC Q&A with Louis Jacques, ADVI Chief Medical Officer
On May 16, the Centers for Medicare and Medicaid Services (CMS) released a tracking sheet for a National Coverage Analysis (NCA) for Chimeric Antigen Receptor (CAR) T-cell therapies. CMS simultaneously announced an August 22 public meeting of its Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) advisory panel meeting on CAR-T therapies.
[/el-text]
Read full article here
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.